The role of IL-12 in the induction of an immune response to a tumor/self peptide: prevention and reversion of anergy.
Belladonna
M L
ML
Department of Experimental Medicine, University of Perugia, Italy. spharmpg@tin.it
Grohmann
U
U
Bianchi
R
R
Ayroldi
E
E
Surace
D
D
Puccetti
P
P
Fioretti
M C
MC
D000818:Animals; D000936:Antigen-Antibody Complex; D000951:Antigens, Neoplasm / Q000276:immunology* / Q000494:pharmacology*; D001247:Asthenia / Q000276:immunology / Q000517:prevention & control*; D017635:Clonal Anergy; D003712:Dendrites / Q000276:immunology / Q000378:metabolism; D000939:Epitopes / Q000276:immunology; D006825:Hybridomas; D006968:Hypersensitivity, Delayed / Q000209:etiology; D007111:Immunity, Cellular; D007376:Interleukin-2 / Q000276:immunology / Q000494:pharmacology*; D008285:Major Histocompatibility Complex / Q000276:immunology*; D051379:Mice; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology
D000936:Antigen-Antibody Complex; D000951:Antigens, Neoplasm; D000939:Epitopes; D007376:Interleukin-2; C076546:tumor rejection antigen P815A, mouse